Glucagon Delivery to Patients with Low Blood Sugar

Particle Therapeutics’ first priority is to provide technology for powder injection of glucagon to individuals with diabetes who are experiencing severe hypoglycaemia (low blood sugar), a condition which requires emergency intervention by third parties.

Standard emergency kits currently contain a needle and syringe, with a powder and liquid which must be mixed and drawn up before injection. Although effective, these kits are rarely used in practice because of their complexity and the fear of administering injections.

The Particle Therapeutics Device is designed to deliver a glucagon powder injection quickly when a patient with diabetes loses, or is near to losing, consciousness. Our device is pressed against the skin and activated simply by pressing a button. Its use is intuitive, so the treatment can be safely administered within seconds by relatives, friends, co-workers or onlookers with no training.

The Pipeline

Our platform technology is capable of supporting a significant pipeline of existing and next-generation versions of therapeutic molecules. We have identified several candidate drugs as particularly suitable, and will add the most promising of these to our pipeline.